MYC and neoplasm: Using a long-distance PCR for IGH-MYC and Sanger sequencing in cases with frozen tumor samples or a genomic capture high-throughput sequencing (gc-hts) assay for IGH-MYC-negative cases and those with FFPE tumor DNA (supplementary methods) [9] IG-MYC breakpoints could be detected in 128 (90%) of the tumor samples.